World's Best Scientists 2026 revealed!
Brent A. Neuschwander-Tetri

Brent A. Neuschwander-Tetri

D-Index & Metrics

Medicine

D-Index
86
Citations
54376
World Ranking
13841
National Ranking
7025

Overview

Brent A. Neuschwander-Tetri is affiliated with Saint Louis University in the United States and has a substantial body of work primarily within the field of Medicine. Their research focuses extensively on hepatology and related subfields.

The scientist's main fields of study include:

  • Medicine

Within Medicine, their subfields of study encompass:

  • Epidemiology
  • Hepatology
  • Endocrinology, Diabetes and Metabolism
  • Cell Biology
  • Surgery

The key topics of research addressed by Neuschwander-Tetri cover areas such as:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Endoplasmic Reticulum Stress and Disease
  • Liver Diseases and Immunity
  • Pancreatitis Pathology and Treatment
  • Alcohol Consumption and Health Effects

Significant recent publications authored or coauthored by them include:

  • "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease," 2020, Gastroenterology
  • "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease," 2023, Hepatology
  • "Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease," 2021, New England Journal of Medicine
  • "Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease," 2023, Hepatology
  • "TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial," 2021, Gastroenterology

Neuschwander-Tetri frequently collaborates with several co-authors, with whom they have multiple joint publications. These include:

  • Rohit Loomba
  • Arun J. Sanyal
  • David E. Kleiner
  • Kris V. Kowdley
  • Danielle Carpenter

Their work appears in prominent journals with recurring publications in:

  • Journal of Hepatology
  • Hepatology
  • The American Journal of Gastroenterology
  • Gastroenterology
  • Hepatology Communications

Best Publications

  • Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

    Elizabeth M Brunt;Christine G Janney;Adrian M Di Bisceglie;Brent A Neuschwander-Tetri

  • Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough

  • Mechanisms of NAFLD development and therapeutic strategies

    Scott L. Friedman;Brent A. Neuschwander-Tetri;Mary Rinella;Arun J. Sanyal

  • Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

    Brent A. Neuschwander‐Tetri;Brent A. Neuschwander‐Tetri;Stephen H. Caldwell;Stephen H. Caldwell

  • MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

    Mohammed Eslam;Arun J Sanyal;Jacob George

  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine

  • Nonalcoholic steatohepatitis: An expanded clinical entity

    Bruce R. Bacon;Mohammad J. Farahvash;Christine G. Janney;Brent A. Neuschwander-Tetri

  • Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

    Brent A. Neuschwander‐Tetri

  • Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings

    Elizabeth M. Brunt;David E. Kleiner;Laura A. Wilson;Patricia Belt

  • Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

    Brent A. Neuschwander-Tetri;Elizabeth M. Brunt;Kent R. Wehmeier;Dana Oliver

  • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

    Stephen Harrison;Dana Oliver;Hays L. Arnold;Sudhanshu Gogia

  • Humanized xenobiotic response in mice expressing nuclear receptor SXR.

    Wen Xie;Joyce L. Barwick;Michael Downes;Bruce Blumberg

  • Nonalcoholic fatty liver disease

    Elizabeth M. Brunt;Vincent W.-S. Wong;Valerio Nobili;Christopher P. Day

  • Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

    Arun J. Sanyal;Mark L. van Natta;Jeanne Clark;Brent A. Neuschwander-Tetri

  • Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

    Stephen A. Harrison;Will Fecht;Elizabeth M. Brunt;Brent A. Neuschwander-Tetri

  • Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

    Kris V. Kowdley;Patricia Belt;Laura A. Wilson;Matthew M. Yeh

  • Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Stephen A Harrison;Stephen A Harrison;Mustafa R Bashir;Cynthia D Guy;Rong Zhou

  • Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

    Brent A. Neuschwander-Tetri;Jeanne M. Clark;Nathan M. Bass;Mark L. Van Natta

  • Severe NAFLD with hepatic necroinflammatory changes in mice fed trans-fats and a high fructose corn syrup equivalent

    Laura H. Tetri;Metin Basaranoglu;Elizabeth M. Brunt;Lisa M. Yerian

  • Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.

    Arun Sanyal;Edgar D Charles;Brent A Neuschwander-Tetri;Rohit Loomba

Frequent Co-Authors

Rohit Loomba
Rohit Loomba University of California, San Diego
Elizabeth M. Brunt
Elizabeth M. Brunt Washington University in St. Louis
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
David E. Kleiner
David E. Kleiner National Institutes of Health
Naga Chalasani
Naga Chalasani Indiana University
Kris V. Kowdley
Kris V. Kowdley Washington State University
James Tonascia
James Tonascia Johns Hopkins University
Joel E. Lavine
Joel E. Lavine Columbia University
Srinivasan Dasarathy
Srinivasan Dasarathy Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternatives or complementary routes to a traditional medical degree, there are diverse online healthcare programs to consider. For non-nursing majors interested in advanced nursing roles, online direct entry MSN programs for non-nursing majors provide a streamlined pathway to earn a master's in nursing without a previous nursing background.

Some aspiring healthcare professionals may prefer training programs with fewer admission hurdles. There are easy nursing programs to get into, making the journey toward becoming a nurse more accessible—even for those without a high GPA or standardized test scores.

Beyond hands-on care, the allied health field offers options like medical billing and coding. Many reputable colleges offer financial aid for medical billing and coding online classes so students can gain in-demand skills for administrative healthcare jobs.

For prospective Licensed Practical Nurses, there’s also the option to enroll in an lpn program without teas test requirements. This can be an ideal choice for those looking to start their nursing career quickly and with fewer entrance barriers.

Best Scientists Citing Brent A. Neuschwander-Tetri

Trending Scientists

Recently Published Articles